D.E. Shaw & Co’s Biote Corp. Warrant BTMDW Stock Holding History

D.E. Shaw & Co’s Portfolio BTMDW Stock Details BTMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-116,961	Closed	-$49.1K	–	4735
2023 Q1	$49.1K	Hold	116,961	–	–	﹤0.01%	4044
2022 Q4	$35.1K	Hold	116,961	–	–	﹤0.01%	4466
2022 Q3	$40K	Hold	116,961	–	–	﹤0.01%	4708
2022 Q2	$33K	Hold	116,961	–	–	﹤0.01%	4914
2022 Q1	$64K	Hold	116,961	–	–	﹤0.01%	5083
2021 Q4	$84K	Hold	116,961	–	–	﹤0.01%	5104
2021 Q3	$94K	Buy	+116,961	New	+$104K	﹤0.01%	4724

Other funds holding BTMDW

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

D.E. Shaw & Co's BTMDW Position: Q2 2023 in Review

D.E. Shaw & Co sold out of Biote Corp. Warrant (BTMDW) in Q2 2023, closing a stake of 116,961 shares — an estimated $49.1K sold.

D.E. Shaw & Co first reported a position in BTMDW in Q3 2021 and held it in 7 quarters. The position peaked at $94K in Q3 2021. 2 funds tracked by Wall St. Rank hold BTMDW as of Q2 2023.

D.E. Shaw & Co reported no remaining Biote Corp. Warrant position as of Q2 2023 after selling out during the quarter.
D.E. Shaw & Co sold 116,961 Biote Corp. Warrant shares in Q2 2023, an estimated $49.1K.
D.E. Shaw & Co first reported a position in Biote Corp. Warrant in Q3 2021 and held it in 7 quarters.
D.E. Shaw & Co's Biote Corp. Warrant position peaked at $94K in Q3 2021.
2 funds tracked by Wall St. Rank held Biote Corp. Warrant as of Q2 2023.

Based on D.E. Shaw & Co's 13F filing for Q2 2023, filed 14 Aug 2023.